Skip to main content

Table 1 nine-month study regimen drugs and doses

From: Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

Product Weight group
Less than 33 kg 33 to 50 kg More than 50 kg
Moxifloxacin 400 mg 600 mg 800 mg
Clofazimine 50 mg 100 mg 100 mg
Ethambutol 800 mg 800 mg 1200 mg
Pyrazinamide 1000 mg 1500 mg 2000 mg
Isoniazid* 300 mg 400 mg 600 mg
Prothionamide* 250 mg 500 mg 750 mg
Kanamycin* 15 mg per kilogram body weight (maximum 1 g)
  1. *Given only during the 16-week intensive phase which can be extended to 20 or 24 weeks in the event of delayed smear conversion.
\